BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19104213)

  • 1. Conducting clinical trials in pediatrics.
    Macrae D
    Crit Care Med; 2009 Jan; 37(1 Suppl):S136-9. PubMed ID: 19104213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric clinical trial experience: government, child, parent and physician's perspective.
    Salazar JC
    Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical research in pediatric nephrology: challenges, and strategies to address them.
    Foster BJ; Warady BA
    J Nephrol; 2009; 22(6):685-93. PubMed ID: 19967646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical considerations in conducting pediatric research.
    Roth-Cline M; Gerson J; Bright P; Lee CS; Nelson RM
    Handb Exp Pharmacol; 2011; 205():219-44. PubMed ID: 21882114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of legislation to regulate pediatric clinical trials: Present and continuing challenges.
    Gans-Brangs KR; Plourde PV
    Adv Drug Deliv Rev; 2006 Apr; 58(1):106-15. PubMed ID: 16530291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials in pediatrics: The drug delivery dimension.
    Osuntokun B
    Adv Drug Deliv Rev; 2006 Apr; 58(1):90-105. PubMed ID: 16529842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical issues of clinical trials in children: a European perspective.
    Sammons H
    Arch Dis Child; 2009 Jun; 94(6):474-7. PubMed ID: 19208673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical issues in pediatric oncology phase I-II trials based on a mother's point of view.
    Oppenheim D; Geoerger B; Hartmann O
    Bull Cancer; 2005 Nov; 92(11):E57-60. PubMed ID: 16316822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving clinical trials of long-term outcomes.
    Rubenfeld GD
    Crit Care Med; 2009 Jan; 37(1 Suppl):S112-6. PubMed ID: 19104210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing paediatric medicines: identifying the needs and recognizing the challenges.
    Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
    J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communicating with children and families: from everyday interactions to skill in conveying distressing information.
    Levetown M;
    Pediatrics; 2008 May; 121(5):e1441-60. PubMed ID: 18450887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trials in overweight children: practicalities and realities.
    Warren JM; Golley RK; Collins CE; Okely AD; Jones RA; Morgan PJ; Perry RA; Baur LA; Steele JR; Magarey AM
    Int J Pediatr Obes; 2007; 2(2):73-85. PubMed ID: 17763014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric stroke initiatives and preliminary studies: What is known and what is needed?
    Sofronas M; Ichord RN; Fullerton HJ; Lynch JK; Massicotte MP; Willan AR; deVeber G
    Pediatr Neurol; 2006 Jun; 34(6):439-45. PubMed ID: 16765821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment in pediatric clinical trials: an ethical perspective.
    Afshar K; Lodha A; Costei A; Vaneyke N
    J Urol; 2005 Sep; 174(3):835-40. PubMed ID: 16093965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric cardiovascular safety: challenges in drug and device development and clinical application.
    Bates KE; Vetter VL; Li JS; Cummins S; Aguel F; Almond C; Dubin AM; Elia J; Finkle J; Hausner EA; Joseph F; Karkowsky AM; Killeen M; Lemacks J; Mathis L; McMahon AW; Pinnow E; Rodriguez I; Stockbridge NL; Stockwell M; Tassinari M; Krucoff MW
    Am Heart J; 2012 Oct; 164(4):481-92. PubMed ID: 23067905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric drug-trial recruitment: enticement without coercion.
    Tishler CL; Reiss NS
    Pediatrics; 2011 May; 127(5):949-54. PubMed ID: 21464193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases.
    van der Lee JH; Wesseling J; Tanck MW; Offringa M
    J Clin Epidemiol; 2008 Apr; 61(4):324-30. PubMed ID: 18313556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes research in pediatric surgery. Part 1: overview and resources.
    Abdullah F; Ortega G; Islam S; Barnhart DC; St Peter SD; Lee SL; Glynn L; Teitelbaum DH; Arca MJ; Chang DC
    J Pediatr Surg; 2011 Jan; 46(1):221-5. PubMed ID: 21238672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls.
    Abdel-Rahman SM; Reed MD; Wells TG; Kearns GL
    Clin Pharmacol Ther; 2007 Apr; 81(4):483-94. PubMed ID: 17329988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.